Jan 10, 2009 - Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy. Keisuke Enomoto,. 1,2.
B Academy of Molecular Imaging, 2009 Published Online: 10 January 2009
Mol Imaging Biol (2009) 11:291 DOI: 10.1007/s11307-008-0196-6
ERRATUM
Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy Keisuke Enomoto,1,2 Hidenori Inohara,1 Ichiro Higuchi,2 Kenichiro Hamada,2 Yoichiro Tomiyama,1 Takeshi Kubo,1 Jun Hatazawa2 1
Department of Otolaryngology, Osaka University School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan Department of Nuclear Medicine and Tracer Kinetics, Osaka University School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan 2
I
n Volume 10, Number 4 (July/August 2008), on page 225, in the “Materials and Methods” section, the second sentence of the subsection “Concurrent CRT” should read: Chemotherapy consisted of six cycle of cisplatin (20 mg/m2) and docetaxel (10 mg/m2). The authors regret the error.
The online version of the original article can be found at http://dx.doi.org/ 10.1007/s11307-008-0145-4 Correspondence to: Keisuke Enomoto; e-mail: keisuke.enomoto@tracer. med.osaka-u.ac.jp
